Cellectar Biosciences (CLRB)Director sold ~$732

~$732

Approx. value · 198 sh @ $3.70

10

Holds after · shares reported

Traded

Dec 12, 2025

Filed

Dec 16, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Nov 13, 2025Company filing · Form 8-K · ResultsReported its results
2. Dec 12, 2025 · this disclosureInsiderDirector sold ~$732 of CLRB shares in the open market

What came next

1. Mar 4, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cellectar Biosciences

OQRO holds no insider, Congress, fund or contract record for Cellectar Biosciences dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CLRB page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Cellectar Biosciences

• SEC Form 4May 12, 2026
• SEC Form 4May 12, 2026
• SEC Form 4Jul 3, 2025
• SEC Form 4Jul 3, 2025
• SEC Form 4Jul 3, 2025
• SEC Form 4Mar 13, 2025

Everything OQRO holds on this company is on its CLRB page.